标题
Cancer epigenetics in clinical practice
作者
关键词
-
出版物
CA-A CANCER JOURNAL FOR CLINICIANS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2022-12-14
DOI
10.3322/caac.21765
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia
- (2022) Pau Montesinos et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA methylation: a historical perspective
- (2022) Alexandra L. Mattei et al. TRENDS IN GENETICS
- 603P Multi-cancer early detection in gynaecological malignancies based on integrating multi-omics assays by liquid biopsy: A prospective study
- (2022) H. Wen et al. ANNALS OF ONCOLOGY
- An Open-Label, Single-Arm, Phase 2 Trial of Valemetostat in Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma
- (2022) Koji Izutsu et al. BLOOD
- Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
- (2021) Huiyan Luo et al. TRENDS IN MOLECULAR MEDICINE
- A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome
- (2021) Gail J. Roboz et al. LEUKEMIA & LYMPHOMA
- The Implementation of DNA Methylation Profiling into a Multistep Diagnostic Process in Pediatric Neuropathology: A 2-Year Real-World Experience by the French Neuropathology Network
- (2021) Melanie Pages et al. Cancers
- Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
- (2021) E.A. Klein et al. ANNALS OF ONCOLOGY
- E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
- (2021) Roisin M. Connolly et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase 1 study of neoadjuvant chemotherapy followed by concurrent chemoradiation with gemcitabine, sorafenib, and vorinostat in pancreatic cancer.
- (2021) Andrew Stewart Poklepovic et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary efficacy from an ongoing phase 1 dose escalation study of seclidemstat (SP-2577) in patients (pts) with advanced solid tumors (AST).
- (2021) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium
- (2021) Steven G. DuBois et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- (2021) David N Louis et al. NEURO-ONCOLOGY
- Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics
- (2021) Zhichao Wu et al. NEURO-ONCOLOGY
- Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
- (2021) Andrew X. Zhu et al. JAMA Oncology
- The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice
- (2021) Lincoln D. Nadauld et al. Cancers
- Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial
- (2021) Charlotte M. Niemeyer et al. Blood Advances
- Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)
- (2021) Emmanuel Bachy et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma
- (2021) Michael Dickinson et al. Blood Advances
- The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes
- (2020) Elisabet Cuyàs et al. Aging-US
- Oral cedazuridine/decitabine: a phase 2, pharmacokinetic/pharmacodynamic, randomized, crossover study in MDS and CMML
- (2020) Guillermo Garcia-Manero et al. BLOOD
- Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
- (2020) William D. Tap et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of tazemetostat, an enhancer of zeste-homolog 2 inhibitor, in patients with relapsed or refractory malignant mesothelioma.
- (2020) Marjorie Glass Zauderer et al. JOURNAL OF CLINICAL ONCOLOGY
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- (2020) M.C. Liu et al. ANNALS OF ONCOLOGY
- The Effect of Advances in Lung-Cancer Treatment on Population Mortality
- (2020) Nadia Howlader et al. NEW ENGLAND JOURNAL OF MEDICINE
- Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
- (2020) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Contribution of Epigenetics to Cancer Immunotherapy
- (2020) Lorea Villanueva et al. TRENDS IN IMMUNOLOGY
- Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML
- (2020) Annalisa Lonetti et al. Cancers
- Chromatin profiling reveals relocalization of lysine-specific demethylase 1 by an oncogenic fusion protein
- (2020) Emily R. Theisen et al. Epigenetics
- Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study
- (2020) Jesper Bonde et al. INTERNATIONAL JOURNAL OF CANCER
- First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
- (2020) Olga Salamero et al. JOURNAL OF CLINICAL ONCOLOGY
- Discovery of CC-90011: A Potent and Selective Reversible Inhibitor of Lysine Specific Demethylase 1 (LSD1)
- (2020) Toufike Kanouni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma
- (2020) Jia Li et al. Science Advances
- BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells
- (2020) Francesco Paolo Fiorentino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
- (2020) Andrew H. Wei et al. NEW ENGLAND JOURNAL OF MEDICINE
- HDAC6 as privileged target in drug discovery: A perspective
- (2020) Sravani Pulya et al. PHARMACOLOGICAL RESEARCH
- Diagnostic accuracy, clinical utility and influence on decision making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer
- (2019) David D'Andrea et al. BJU INTERNATIONAL
- Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity
- (2019) Hao Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study
- (2019) Frederique J. Vink et al. INTERNATIONAL JOURNAL OF CANCER
- DNA Methylation Cancer Biomarkers: Translation to the Clinic
- (2019) Warwick J. Locke et al. Frontiers in Genetics
- The Histone Demethylase LSD1/ΚDM1A Mediates Chemoresistance in Breast Cancer via Regulation of a Stem Cell Program
- (2019) John Verigos et al. Cancers
- Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
- (2019) Gail J. Roboz et al. BLOOD
- Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
- (2018) Ka Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
- (2018) Chaoyang Sun et al. CANCER CELL
- LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
- (2018) Wanqiang Sheng et al. CELL
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients
- (2018) Magdalena Absmaier et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression
- (2018) Chong Qin et al. JOURNAL OF MEDICINAL CHEMISTRY
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
- (2018) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett’s esophagus
- (2018) Helen R. Moinova et al. Science Translational Medicine
- Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men
- (2018) Robert L. Waterhouse et al. UROLOGY
- Identification of a robust methylation classifier for cutaneous melanoma diagnosis
- (2018) Kathleen Conway et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia
- (2017) Ting Luan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
- (2017) Gunter Weiss et al. Journal of Thoracic Oncology
- BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment
- (2017) Georg E. Winter et al. MOLECULAR CELL
- Mapping DNA methylation with high-throughput nanopore sequencing
- (2017) Arthur C Rand et al. NATURE METHODS
- Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary
- (2017) Sebastián Moran et al. Nature Reviews Clinical Oncology
- Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
- (2017) Michael Karremann et al. NEURO-ONCOLOGY
- Repression of BET activity sensitizes homologous recombination–proficient cancers to PARP inhibition
- (2017) Lu Yang et al. Science Translational Medicine
- HDAC inhibition potentiates immunotherapy in triple negative breast cancer
- (2017) Manuela Terranova-Barberio et al. Oncotarget
- BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
- (2017) Sergey Karakashev et al. Cell Reports
- DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma
- (2017) Jin Huang et al. International Journal of Environmental Research and Public Health
- Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria
- (2016) Kim E.M. van Kessel et al. JOURNAL OF UROLOGY
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Surveillance after curative treatment for colorectal cancer
- (2016) Eric P. van der Stok et al. Nature Reviews Clinical Oncology
- Toward a Shared Vision for Cancer Genomic Data
- (2016) Robert L. Grossman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erratum: Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
- (2016) S Sankar et al. ONCOGENE
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences
- (2016) Sebastian Moran et al. Epigenomics
- A cross-sectional study comparing a blood test for methylatedBCAT1 and IKZF1tumor-derived DNA with CEA for detection of recurrent colorectal cancer
- (2016) Graeme P. Young et al. Cancer Medicine
- Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
- (2015) Y. Shi et al. ANNALS OF ONCOLOGY
- MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles
- (2015) Ming Yu et al. Epigenetics
- Loss of BAP1 function leads to EZH2-dependent transformation
- (2015) Lindsay M LaFave et al. NATURE MEDICINE
- Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
- (2015) Timothy J. Stuhlmiller et al. Cell Reports
- Targeting the histone orthography of cancer: drugs for writers, erasers and readers
- (2014) Laia Simó-Riudalbas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Validation of a Real-Time PCR-Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma
- (2014) N. T. Potter et al. CLINICAL CHEMISTRY
- Validation of DNA methylation profiling in formalin-fixed paraffin-embedded samples using the Infinium HumanMethylation450 Microarray
- (2014) Sebastián Moran et al. Epigenetics
- Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies
- (2014) Alan W. Partin et al. JOURNAL OF UROLOGY
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Multitarget Stool DNA Testing for Colorectal-Cancer Screening
- (2014) Thomas F. Imperiale et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Promising DNA Methylation Signature for the Triage of High-Risk Human Papillomavirus DNA-Positive Women
- (2014) Alfred Hansel et al. PLoS One
- Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study
- (2014) David A. Johnson et al. PLoS One
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging
- (2013) K. Darwiche et al. ANNALS OF ONCOLOGY
- Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair
- (2013) B Groselj et al. BRITISH JOURNAL OF CANCER
- LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer
- (2013) J Ding et al. BRITISH JOURNAL OF CANCER
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study
- (2012) Grant D. Stewart et al. JOURNAL OF UROLOGY
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models
- (2012) Li Shen et al. PLoS One
- Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer
- (2012) Tangfeng Lv et al. PLoS One
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome
- (2011) Juan Sandoval et al. Epigenetics
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
- (2011) M Fernanda Amary et al. JOURNAL OF PATHOLOGY
- Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling
- (2011) Hongcang Gu et al. Nature Protocols
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Replication timing-related and gene body-specific methylation of active human genes
- (2010) Dvir Aran et al. HUMAN MOLECULAR GENETICS
- Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma
- (2010) Jörg Ellinger et al. INTERNATIONAL JOURNAL OF CANCER
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole genome DNA methylation analysis based on high throughput sequencing technology
- (2010) Ning Li et al. METHODS
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Targeting DNA methylation for epigenetic therapy
- (2010) Xiaojing Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Global Levels of Histone Modifications Predict Prognosis in Different Cancers
- (2009) David B. Seligson et al. AMERICAN JOURNAL OF PATHOLOGY
- Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
- (2009) Soyoung Lim et al. CARCINOGENESIS
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2009) Lenny Dang et al. NATURE
- Human DNA methylomes at base resolution show widespread epigenomic differences
- (2009) Ryan Lister et al. NATURE
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
- (2009) Elaine R. Mardis et al. NEW ENGLAND JOURNAL OF MEDICINE
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in Glioma
- (2008) Ilse Vlassenbroeck et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
- (2008) Jing Wang et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation